Tuesday, December 1, 2009

FDA Approval for Dyax's Genetic Disorder Drug, Kalbitor - TransWorldNews (press release)


FDA Approval for Dyax's Genetic Disorder Drug, Kalbitor
TransWorldNews (press release)
... the rare disorder causes swelling in extremities, the intestinal tract or airways. Dyax stock jumped in after-hours trading, up $1.33 or 38 percent.

and more »

No comments:

Post a Comment